FOXP3 and amyotrophic lateral sclerosis: The proportion of the FL FoxP3 splice variant was decreased to 32.1 ± 4.7% (median 33.6%) in Tregs from ALS patients compared to 48.1 ± 3.5% (median 43.9%) in healthy donors.